Expanding Patient Access to Gene Therapies Through AAV Capsid Engineering

Capsid engineering can increase AAV capsids’ specificity, transduction efficiency, and manufacturability while reducing unwanted immune responses. Such improvements have the potential to broaden the range of diseases that can be treated with gene therapies and greatly expand access to patients.

Request Free!